A Study of V110 a Pneumococcal Vaccine in Healthy Adults (V110-013)
NCT00127153
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
130
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Pneumococcal Infections
Interventions
BIOLOGICAL:
V110, pneumococcal vaccine polyvalent
Sponsor
Merck Sharp & Dohme LLC